MedPath

Hematopietic stem cell transplantation from HLA 2-3 antigen-mismatched family donor using reduced intensity conditioning

Phase 2
Conditions
hematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantaiton
Registration Number
JPRN-UMIN000023784
Lead Sponsor
Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) allergic for drugs used in this protocol 2) active CNS lesion (exclude original disease) 3) active infection 4) when the physician in chief decides the patient is inappropriate for this protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath